{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (Q3 FY26)",
      "prediction": "BEAT",
      "answer": "pred ~$4.42 vs. cons $4.37",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Revenue (Q3 FY26)",
      "prediction": "MISS",
      "answer": "pred ~$83.4B vs. cons $84.89B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "U.S. Healthcare Solutions Segment Revenue (Q3 FY26)",
      "prediction": "MISS",
      "answer": "pred ~$73.8B vs. cons $75.0B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 Adjusted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$17.85-$18.05 (mid $17.95) vs. cons $17.85 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Revenue growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~5% (4-6% range reaffirmed) vs. cons ~5.1% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "U.S. Healthcare Solutions operating income growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~15% (14-16% range reaffirmed) vs. cons ~14% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "An EPS beat driven mainly by buybacks/cost control plus reaffirmed (not raised) FY revenue guidance should spark an initial relief rally given the stock's pre-print underperformance vs. SPY (-4% into the print) and post-May de-risked positioning. But this would be the third straight quarter of revenue undershoot on WAC/IRA, mail-order biosimilar mix-shift and decelerating GLP-1 growth, so sell-side analysts are likely to trim FY27/out-period organic revenue and gross-profit-dollar assumptions even while nudging EPS estimates up for the buyback tailwind \u2014 a classic 'lower-quality beat' pattern that fades initial upside over the week as the implicit revenue-guide cut (still officially 4-6% but tracking toward the low end) gets modeled through.",
  "day5_confidence": "LOW"
}